EFI to Present at Upcoming Stifel and William Blair Conferences
May 26, 2017 12:31 pm UTC| Business
FREMONT, Calif., May 26, 2017 -- Electronics For Imaging, Inc. (NASDAQ:EFII), a world leader in customer-focused digital printing innovation, today announced that management will present at Stifel’s 2017 Technology,...
EFI to Present at Upcoming Stifel and William Blair Conferences
May 26, 2017 12:31 pm UTC| Business
FREMONT, Calif., May 26, 2017 -- Electronics For Imaging, Inc. (NASDAQ:EFII), a world leader in customer-focused digital printing innovation, today announced that management will present at Stifel’s 2017 Technology,...
BroadSoft Announces Participation in Upcoming Investor Conferences in June 2017
May 26, 2017 12:31 pm UTC| Business
GAITHERSBURG, Md., May 26, 2017 -- BroadSoft, Inc. (NASDAQ:BSFT), today announced it will participate in the following investor conferences during the month of June 2017. On June 8th, 2017, BroadSoft will participate...
BroadSoft Announces Participation in Upcoming Investor Conferences in June 2017
May 26, 2017 12:31 pm UTC| Business
GAITHERSBURG, Md., May 26, 2017 -- BroadSoft, Inc. (NASDAQ:BSFT), today announced it will participate in the following investor conferences during the month of June 2017. On June 8th, 2017, BroadSoft will participate...
Yield10 Bioscience Announces 1-for-10 Reverse Stock Split
May 26, 2017 12:30 pm UTC| Business
WOBURN, Mass., May 26, 2017 -- Yield10 Bioscience, Inc. (NASDAQ:YTEN) announced today that it will effect a 1-for-10 reverse stock split of its common stock, following stockholder approval of the reverse stock split at...
May 26, 2017 12:25 pm UTC| Business
LAFAYETTE, La., May 26, 2017 -- PetroQuest Energy, Inc. (NYSE:PQ) today announced that it has extended the expiration date of its offer to exchange (the “Exchange Offer”) (i) up to $14,177,000 of 10%Second Lien Senior...
Achaogen Announces Multiple Plazomicin Presentations at ASM Microbe 2017 Annual Meeting
May 26, 2017 12:03 pm UTC| Business
- Two oral presentations highlighting data from plazomicin Phase 3 EPIC and CARE clinical trials - - Eleven poster presentations highlighting plazomicin’s activity against MDR Enterobacteriaceae, including...